|

Homepage
Sitemap


|
Interleukin Genetics and ScHARR Economic Modeling Study Demonstrates Potential Cost Benefit of IL-1 Pharmacogenetic Testing before Rheumatoid Arthritis Business Editors & Health/Medical Writers BIOWIRE2K WALTHAM; Mass.--(BUSINESS WIRE)--Oct. 28; 2002 Abstract Presented at American College of Rheumatology's ...
The People's Pharmacy - rheumatoid arthritis treatment Faced with the pain of rheumatoid arthritis; many Chinese seek relief in a weed called thunder god vine; which grows wild in southern China. Now Stanford ...
Coulter Pharmaceutical Acquires Rights to Novel Technology Related to Rheumatoid Arthritis Treatment Business Editors/Health & Medical Writers SOUTH SAN FRANCISCO; Calif.--(BW HealthWire)--Oct. 2; 2000 Coulter Pharmaceutical; Inc. (Nasdaq:CLTR) today announced that it has entered into a licens
Corixa Receives $1 Million Milestone Payment from Organon as Part of Rheumatoid Arthritis Treatment Collaboration Business Editors/Health & Medical Writers BIOWIRE2K SEATTLE--(BW HealthWire)--April 17; 2000 Randomized; Blinded; Placebo-Controlled; Phase I/II Dose Escalation Trial Completed Corixa Cor
SAB-Pharma - Supplier News - SAB-Pharma offers gold sodium thiomalate as rheumatoid arthritis treatment in the United States - Brief Article SAB-Pharma announced that its gold sodium thiomalate is available for treating select cases of active rheumatoid arthritis in adults and children. The ...
Rheumatoid arthritis treatment approved Medication Update The FDA approved Abbott's adalimumab (HUMIRA) for the treatment of rheumatoid arthritis (RA). The medication is indicated to reduce ...
PROSORBA Column European Product Launch Announced; Novel Rheumatoid Arthritis Treatment Now Available in Western and Central Europe Business Editors/Health & Medical Writers LISBON; Portugal--(BW HealthWire)--April 7; 2000 Cypress Bioscience Inc. (Nasdaq:CYPB) and Fresenius HemoCare ...
|